Skip to content

A double-blind, randomized, placebo-controlled clinical study to investigate the effect of the beverage containing plant extracts

A double-blind, randomized, placebo-controlled clinical study to investigate the effect of the beverage containing plant extracts - A clinical study to investigate the effect of the beverage containing plant extracts

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000023491
Enrollment
150
Registered
2017-09-30
Start date
2016-08-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

The beverage containing plant extract, 12 weeks The beverage non-containing plant extract, 12 weeks

Sponsors

Fukuhara Clinic
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Males and females equal to or more than 20 years and less than 65 years of age 2.Healthy males and females with no treatment 3.Subjects equal to or more than 25 and less than 30 kg/m^2 of BMI at the pre-study 4.VFA level is above 80 cm^2 5.Subjects who recognize the object and contents of the study and submit the written informed consent

Exclusion criteria

Exclusion criteria: 1.Subjects who have marked impairment of liver, kidney, heart, lung, endocrine, metabolism, nerve, or consciousness, or have DM 2.Subjects who have historical disease of circulatory system disease 3.Subjects who use drugs of glycometabolism, lipidmetabolism, or reducing high blood pressure 4.Subjects who regularly use drugs, health foods, supplements which are suggested causal relationship from the study except who agree to quit taking them 5.Subjects who have allergy related to the test foods 6.Subjects who feel bad mood by blood collection in past 7.Subjects who donated 200 mL or more of blood within a month prior to the study. 8.Subjects who participate in other clinical trials within the last 4 weeks prior to the current study 9.Heavy dinkers or heavy smokers 10.Subjects whose eating habits are extremely irregular 11.Pregnant and lactating female, or who wish to get pregnant during the study period. 12.Subjects who can not agree with preliminary explanation. 13.Subjects who are ineligible due to physician's judgment.

Design outcomes

Primary

MeasureTime frame
Visceral fat area, at 8 and 12 weeks after intake

Countries

Japan

Contacts

Public ContactShimpei Tomita

New drug research center, Inc. Clinical Research Dept.

s-tomita@ndrcenter.co.jp0123-34-0412

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026